MEDS: Dhuwit awis perusahaan TRxADE Health Corp

Simbol resmi perusahaan TRxADE HEALTH (MEDS)

A high barrier to entry is ensured by the IT system for pharmacies and strict FDA and DEA oversight for TRxADE HEALTH, Inc. (MEDS). The company's cash liquidity visualizes financial stability, where 0.00 determines the current status of the parameter. Revenues are based on the marketplace and telemedicine. However, competition with tech giants is gradually eroding defensive advantages as the company transitions into the digital healthcare services segment.

MEDS - Sisa dhuwit perusahaan TRxADE Health Corp ing rentang 04.07.2022 - 21.11.2026

Rincian analitis lan laporan data perusahaan TRxADE HEALTH Inc (MEDS)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:trxadehealth.com
Produk merek TRxADE HEALTH

This indicator measures the issuer's immediate liquidity, determining its ability to service obligations and pay dividends without seeking external financing. Monitoring this parameter allows an investor to ignore market volatility by relying on the actual cash balance. By analyzing the cash balance recorded at 0.00, one can assess the financial stability of the business. An optimal reserve prevents default without restricting expansion. For TRxADE HEALTH (MEDS), such capital transparency confirms the reliability of the largest digital pharmaceutical distributor in the US.

Pesaing TRxADE HEALTH, Inc.

Volume dana dhuwit perusahaan VEEV|Doximity, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|HealthEquity - Dhuwit awis perusahaan|Aset likuid perusahaan Waystar Health (WAY)|CRVL - Dana dhuwit perusahaan|Sisa dhuwit perusahaan PRVA (Privia Health Group)|HURN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan certara.com (CERT)|Dana dhuwit perusahaan Omnicell Inc|GoodRx Corp (GDRX) - Aset likuid perusahaan|Dhuwit awis perusahaan SDGR (Schrodinger Corp)|Aset likuid perusahaan Phreesia, Inc.|Dana dhuwit perusahaan Omada Health, Inc. OMDA|EVH - Dhuwit awis perusahaan|HealthStream - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan DH (Definitive Healthcare Corp.)|Consensus (CCSI) - Dana dhuwit perusahaan|Dhuwit awis perusahaan agilon health Inc|ABSI (absci.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan SY|Dhuwit awis perusahaan NRC (National Research Corp)|SPOK - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan OptimizeRx Corporation OPRX|TBRG - Dhuwit awis perusahaan|SLP - Dana dhuwit perusahaan|Aset likuid perusahaan Sophia Genetics SOPH|HCAT (Health Catalyst, Inc.) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CCLD|Dhuwit awis perusahaan RSSS|DLHC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan ONMD|Scienture Holdings Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Healthcare Triangle Inc HCTI|ISPC (iSpecimen Corp) - Total volume dana dhuwit perusahaan|BFRG - Dana dhuwit perusahaan|WORX (SCWorx Corp.) - Dhuwit awis lan setara dhuwit awis perusahaan|LifeWallet (MSPR) - Dana dhuwit perusahaan|Dhuwit awis perusahaan iCoreConnect Corp|ORGS (Orgenesis Corporation) - Volume dana dhuwit perusahaan|RCM: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SHCR|Dhuwit awis perusahaan Streamline Health Solutions Inc. STRM|Syra Health Corp. - Dhuwit awis perusahaan|ApolloMed (AMEH) - Cadangan dhuwit perusahaan|Model N Inc - Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan NextGen Healthcare, Inc. (NXGN)